Physicochemical characterization of drug nanocarriers
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmaceutical design has enabled important advances in the prevention, treatment, and diagnosis of diseases. The use of nanotechnology to optimize the delivery of drugs and diagnostic molecules is increasingly receiving attention due to the enhanced efficiency provided by these systems. Understanding the structures of nanocarriers is crucial in elucidating their physical and chemical properties, which greatly influence their behavior in the body at both the molecular and systemic levels. This review was conducted to describe the principles and characteristics of techniques commonly used to elucidate the structures of nanocarriers, with consideration of their size, morphology, surface charge, porosity, crystalline arrangement, and phase. These techniques include X-ray diffraction, small-angle X-ray scattering, dynamic light scattering, zeta potential, polarized light microscopy, transmission electron microscopy, scanning electron microcopy, and porosimetry. Moreover, we describe some of the commonly used nanocarriers (liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, and micelles) and the main aspects of their structures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








![Figure 9 SAXS curves of the systems developed by Negrini et al,52 showing the reversibility of the mesophase following pH changes (pH 7 [lower curve] → pH 2 [middle curve] → pH 7 [upper curve]). Adapted with permission, from: Negrini R, Mezzenga R, pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27(9), 2011, 5296–5303. Copyright 2017 American Chemical Society.52](https://figures.cochat.ai/paper-figures/096693895aa54288922b19e5981ebb0f/physicochemical-characterization-of-drug-nanocarriers-figure-9.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“60 Finally, third-generation liposomes have been developed with targeting molecules (antibodies and peptides) on their surfaces in order to provide receptor recognition and active targeting of the drug.”
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., Eubank, J. F., Heurtaux, D., Clayette, P., Kreuz, C., et al. (2010) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,260 · cited 1×
“104 Compared with conventional porous materials, advantages of NMOFs include the ability to incorporate large amounts of drugs as well as their adjustable composition and structure.”
Transmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963 · cited 4×
“This is identical, in principle, to the more familiar medical computerized axial tomography (CAT) scans using X-rays.”
InfluentialDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848 · cited 1×
“87–89 More recently, discoveries based on inorganic nano-particles, such as mesoporous silica nanoparticles (MSNs), have opened up exciting new possibilities in this area.”
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 1×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · cited 1×
“Introduction Recent years have seen increasing research interest in the development of new drug delivery systems that are based on nanoparticles with dimensions ranging from 1 to 1,000 nm.(1) Compared to conventional drug delivery systems, the use of nanoparticles for drug delivery offers advantages, including high st…”
BackgroundSolid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150 · cited 2×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Metal–organic frameworks: a new class of porous materials
Rowsell, J. L. C., & Yaghi, O. M. (2004) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2004.03.034 · Cited by 2,963
Mesoporous Materials for Drug Delivery
Vallet‐Regí, M., Balas, F., & Arcos, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604488 · Cited by 2,507 · cited 3×
“85 The pore diameter can typically be altered in the range from 2 to 50 nm by changing the components of these materials, enabling the production of various mesoporous materials that are able to host small drug molecules or macromolecules.”
Influential
Cited by
Items 101–200 of 216
Caicedo-Casso, E. A., Bice, J. E., Nielsen, L. R., Sargent, J., Lindberg, S. E., & Erk, K. A. (2019) · Rheologica Acta · doi:10.1007/s00397-019-01147-x · Cited by 9
“(Manaia et al., 2017) The domain size parameter for this structure was calculated from q* to be d = 55.0 Å.”
MethodInfluentialQuality Evaluation of Drug-Loaded Liposomes
Lin, M. S., Wang, R., & Qi, X. (2018) · Biomaterial engineering · doi:10.1007/978-3-662-49231-4_25-1 · Cited by 9
Nano-based formulations as an approach for providing a novel identity for organoselenium compounds
Sari, M. H. M., Ferreira, L. M., Prado, V. C., Nogueira, C. W., & Cruz, L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.07.018 · Cited by 9
Güncüm, E., Bakırel, T., Anlaş, C., Işıklan, N., Alkan, F. Ü., Charehsaz, M., & Aydın, A. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.001 · Cited by 9
Charge and rigidity effects on the encapsulation of quercetin by multilamellar vesicles
Custódio, L., Mendes, L. A., Alvares, D. S., Moreto, J. A., & Slade, N. B. L. (2022) · Bulletin of Materials Science · doi:10.1007/s12034-022-02734-0 · Cited by 7
Nanocarriers in drug delivery system: Eminence and confront
Sultana, N., Bora, P., & Sarma, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816770-0.00010-1 · Cited by 11
Calixto, G. M. F., Victorelli, F. D., Franz‐Montan, M., Baltazar, F., & Chorilli, M. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3025 · Cited by 8
Physicochemical Characterization of Silver Sulfadiazine in Polymeric Wound Dressings
de Melo, D. F., Guedes, G. G., Moreira, L. M. C. D. C., Oshiro, J. A., & Damasceno, B. P. G. D. L. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230324122925 · Cited by 7
Micro and nanoemulsion as drug carriers in Alzheimer's disease
Patel, A. K., Paliwal, H., Sawant, K. K., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00013-3 · Cited by 9
Opportunities and Challenges of Silicon‐based Nanoparticles for Drug Delivery and Imaging
Karaman, D. Ş., Kaasalainen, M. H., Kettiger, H., & Rosenholm, J. M. (2020) · Wiley eBooks · doi:10.1002/9781119414018.ch9 · Cited by 7
Gorish, B. M. T., Abdelmula, W. I. Y., Wenqian, D., Yue, B., Yahu, L., & Zhu, D. (2026) · Small · doi:10.1002/smll.202513085 · Cited by 8
Fahim, Y. A., Hasani, I. W., & Kabba, S. (2026) · Discover Nano · doi:10.1186/s11671-026-04643-1 · Cited by 7
“SEM provides detailed images of NPs morphology by scanning an electron beam across the sample surface under vacuum [36].”
Jammor, P., Sanguanphun, T., Meemon, K., Promdonkoy, B., & Boonserm, P. (2024) · ACS Omega · doi:10.1021/acsomega.3c08653 · Cited by 6
Exploring the Antimelanoma Potential of Betulinic Acid Esters and Their Liposomal Nanoformulations
Milan, A., Mioc, M., Mioc, A., Marangoci, N. L., Racoviceanu, R., Mardale, G., Bălan, M., Rotunjanu, S., Şoica, I., & Şoica, C. (2024) · Processes · doi:10.3390/pr12020416 · Cited by 7
Nanostructured Lipid Carriers for oral treatment of leishmaniasis: Design and preclinical evaluation
de Souza, M. L., Sales, V. D. A. W., Sales, S. G. D. S., Sales, P. A., Pereira, V. R. A., de França, E. J., Rolim, L. A., & Neto, P. J. R. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.134140 · Cited by 6
Madheswaran, T., Chellappan, D. K., Lye, F. S. N., & Dua, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2474693 · Cited by 6
“…system causes a deviation in the plane of polarized light (birefringence, similar to real crystals) when using an additional λ-plate which results in typical black-and-white images or colored textures that aid in distinguishing between mesophases based on their characteristic textures [65,77].”
InfluentialUnravelling drug delivery using in vitro Fluorescence Correlation Spectroscopy (FCS)
van den Hoven, L., Goddaer, S., Mirzahossein, E., Vermonden, T., Koynov, K., Remaut, K., & van Ravensteijn, B. G. P. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114311 · Cited by 6
Carrageenan-Based Drug Delivery Systems for Respiratory Disease
Gupta, N. V., Chakraborty, S., Veeranna, B., Osmani, R. A. M., Moin, A., Koduru, T. S., Sharadha, M., & Ramkishan, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-7656-8_20 · Cited by 6
Kesavan, A., Reddy, U. C., Kurian, J., & Muraleedharan, K. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103439 · Cited by 6
Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics
Singh, C. P., Rai, P. K., Kumar, M., Tiwari, V., Tiwari, A., Sharma, A., & Sharma, K. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230727102213 · Cited by 6
Ibrahim, S. O., Lukman, H. Y., Ebhohimen, I. E., Babamale, H. F., Abdulkadir, F. R., Hamid, A. A., Zubair, M. F., & Atolanı, O. (2024) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v7i2.6820 · Cited by 5
“Molecular weight (MW) is a crucial physicochemical property affecting processes like absorption and interaction with targets 24,25 .”
BackgroundVitek, M., Pobirk, A. Z., Roškar, R., & Matjaž, M. G. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2460708 · Cited by 5
“…with oily streaks denote the presence of lamellar mesophases, while fan-like textures indicate formation of hexagonal mesophases. a dark background, with no birefringence, suggests the presence of cubic mesophases, known for their isotropic liquid behavior (Manaia et al., 2017; Zhang et al., 2020).”
Regulatory issues and toxicological concerns related to nanocarriers
Kataki, M. S., Singh, J., Rajkumari, A., & Kakoti, B. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00027-3 · Cited by 5
Ye, Z., Abdelmoaty, M. M., Curran, S. M., Dyavar, S. R., Kumar, D., Alnouti, Y., Coulter, D. W., Podany, A. T., Singh, R. K., & Vetro, J. A. (2022) · Non-Coding RNA · doi:10.3390/ncrna8010008 · Cited by 5
“Polyplex diameter and surface charge are two physicochemical properties that can potentially affect the activity of polyplexes after IV administration [9,10].”
BackgroundComparison of ion selectivities of nitrite channel NirC and water channel aquaporin
Yılmaz, H., Erdoğan, E. M., Ergenekon, P., & Özkan, M. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03553-z · Cited by 5
Optimization of Cream Formulation Containing Leaf Extract and Chitosan Nanoparticles
Parwati, P., & Wikantyasning, E. R. (2023) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v7i11.22 · Cited by 5
Tereshkina, Y. A., Bedretdinov, F. N., & Kostryukova, L. V. (2023) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20236906409 · Cited by 5
Saadh, M. J., Shallan, M. A., Hussein, U. A., Mohammed, A. Q., Al-Shuwaili, S. J., Shikara, M. D., Ami, A. A., Khalil, N. A. M. A., Ahmad, I., Abbas, H. H., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03033-7 · Cited by 5
“Additionally, TEM can identify any structural alterations or deformations in lipid nanocarriers caused by environmental factors or during the encapsulation process, which can impact their stability and drug release kinetics (Manaia 2017).”
RetractedLiquid crystalline drug delivery systems
Nalone, L. A., Marques, C., Costa, S. P. M., Souto, E. B., & Severino, P. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817870-6.00007-9 · Cited by 5
Jessica, A., AINA, S., Rahayu, R., & AGUSTIN, R. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025.v17s1.02 · Cited by 4
“The acceptable range for zeta potential indicating good colloidal stability is above+30 mV or below-30 mV [23].”
Pandi, J. S., Pavadai, P., Theivendren, P., Murugesan, S., & Kunjiappan, S. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae3411 · Cited by 4
“In general, a semicrystalline system interacts well with biological liquids, which can be used to penetrate tissue layers and give excellent diffusion properties for nanocarriers carrying medication molecules [68].”
Bellotti, M., Chiesa, E., Giglio, A., Genta, I., Conti, M., Auricchio, F., & Caimi, A. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.175464 · Cited by 4
Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 5
Saini, K., Verma, M. K., Kaur, I. P., & Kakkar, V. (2022) · Current Nanoscience · doi:10.2174/1573413718666220414151940 · Cited by 4
Köse, S., Varan, C., Önen, S., Nemutlu, E., Bilensoy, E., & Korkusuz, P. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03902-1 · Cited by 5
“A Malvern Zetasizer Nano ZS (Worcestershire, UK) instrument with dynamic light scattering (DLS) was used to determine the particle size, PDI, zeta potential and surface charge [41, 42].”
MethodSoares, D. C. F., Arribada, R. G., de Barros, A. L. B., & Tebaldi, M. L. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2019.1581779 · Cited by 4
Chiavacci, L. A., da Silva, B. L., Corrêa, A. G. S., & Pulcinelli, S. H. (2022) · Journal of Sol-Gel Science and Technology · doi:10.1007/s10971-021-05690-z · Cited by 4
“proportion of 80% of the material ureasil-POP400 and 20% of ureasil-POE1900, it was possible to obtain a membrane with a low inflammatory response [53].”
BackgroundSelf-citationNanomaterials for Drug Delivery
Bal, Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00011-8 · Cited by 4
CD4+ T cell-targeting immunoliposomes for treatment of latent HIV reservoir
Meeroekyai, S., Jaimalai, T., Suree, N., & Prangkio, P. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.12.006 · Cited by 4
Ricci‐Júnior, E., Rosa, A. D. S., do Nascimento, T., Santos‐Oliveira, R., da Silva, M. A. N., Barreto-Vieira, D. F., Batista, L. T., da Conceição, G. B., Quintão, T. A. N., Ferreira, V. N. S., et al. (2025) · Viruses · doi:10.3390/v17040518 · Cited by 3
“…evaluated during the development of nanosystems because they provide information on stability, formation of aggregates in the dispersion, and particle size [49,50]. characteristics will determine the behavior of these systems after in vivo administration, such as pharmacokinetic parameters [51,52].”
Moringa oleifera fixed oil–composed lyotropic liquid crystals for the delivery of resveratrol
Silveira, D. K. D. A., do Nascimento, P. E. S., Lisboa, E. S., Farias, B. M. C., Souza, D. E. S., Freitas, L. D. S., Santos, A. D. J., Santos‐Oliveira, R., Cardoso, J. C., Soares, C. M. F., et al. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128630 · Cited by 3
Hussain, A., Khan, T., Siddique, M. U. M., Danishuddin, Altamimi, M. A., & Ramzan, M. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100378 · Cited by 3
“Various primary physicochemical properties including particle size, particle morphology, and drug-excipient interaction influence the drug solubility (Manaia et al., 2017).”
da Silva, B. L., Garcia, M. M., Oshiro, J. A., Sato, M. R., Caetano, B. L., & Chiavacci, L. A. (2022) · Journal of Sol-Gel Science and Technology · doi:10.1007/s10971-021-05681-0 · Cited by 3
“Thus, near the IP, the agglomeration of the NP tends to increase [35].”
BackgroundSelf-citationQuality Evaluation of Drug-Loaded Liposomes
Lin, M. S., Wang, R., & Qi, X. (2021) · Biomaterial engineering · doi:10.1007/978-3-662-49320-5_25 · Cited by 3
Nanocarriers for siRNA Delivery Aimed at the Treatment of Melanoma: Systematic Review
de Araujo, B. R., do Nascimento, T., Matos, A. P. D. S., Belmiro, V. B. D. S., Monteiro, M. S. D. S. D. B., Santos‐Oliveira, R., & Ricci‐Júnior, E. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230425234700 · Cited by 3
Physical Characterization to Improve Scalability and Potential of Anesthetic-Loaded Nanodroplets
Ting, S. G., Lea‐Banks, H., & Hynynen, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082077 · Cited by 3
“Examples of physicochemical characterization commonly include particle diameter, particle size distribution, morphology, and drug release profiles [11].”
BackgroundShape Effect of Polymer-Based Multilayer Microcapsules on Cellular Internalization
Zhang, X., Han, J., Ding, T., Cao, J., Zan, X., Guo, Y. B., & Bao, H. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c03688 · Cited by 3
Comprehensive Review on the Development of Phytonanomedicines for Cancer Treatment
Fernandes, D. A. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00280-x · Cited by 3
“Properties of nanoparticles such as molecular weight, shape, size, composition, charge, solubility and aggregation behavior greatly influence their effectiveness for treating cancer [177, 178].”
Malheiros, B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2018.tde-18122018-172044 · Cited by 3
Pont, I., Felipe, R., Frias, J. C., Chicote, J. U., García‐España, A., García‐España, E., & Albelda, M. T. (2024) · Biomolecules · doi:10.3390/biom14111347 · Cited by 2
do Nascimento, T., Cardoso, V. D. S., Santos‐Oliveira, R., Barreto-Vieira, D. F., Vermelho, A. B., & Ricci‐Júnior, E. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107243 · Cited by 5
SISTEMA DE LIBERAÇÃO CONTROLADA DE QUIMIOTERÁPICOS BASEADO EM NANOPARTÍCULAS: REVISÃO INTEGRATIVA
Cardoso, R. R., Galvão, J. G. F. M., Marques, A. E. F., & de Araújo, D. I. A. F. (2025) · Revista Multidisciplinar do Nordeste Mineiro · doi:10.61164/m8xd2x31 · Cited by 2
Elvira, E.-F., Rosales‐Rivera, L. C., Morral-Ruíz, G., Franco-García, Á., Kakabadze, T., & García, M. J. N. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107945 · Cited by 2
Rahma, S., Amalia, E., & Kusuma, S. A. F. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s607567 · Cited by 2
Barbhuiya, R. I., Ramalingam, S., Kalra, H. K., Elsayed, A., Routray, W., Manickavasagan, A., & Singh, A. (2022) · Biophysica · doi:10.3390/biophysica2030016 · Cited by 2
Pippa, Ν., Katifelis, H., Gazouli, M., & Pispas, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00006-7 · Cited by 2
Kraevsky, S. V., Ivanova, I. A., Kanashenko, S. L., Shumov, I. D., Ryazantsev, I. A., Tereshkina, Y. A., Kostryukova, L. V., Romashova, Y. A., & Pleshakova, T. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015338 · Cited by 2
“As described in [37], zeta-potential values greater than +30 mV and lower than − 30 mV indicate conditions of stability, while the values between − 30 mV and +30 mV indicate conditions of stability favoring the aggregation, coagulation, and flocculation of the particles.”
BackgroundCardoso, V. D. F., Batista, C. N. D. S., Moura, M. L., da Rocha, L. V. M., & Gomes, A. C. D. O. (2024) · Seven Editora eBooks · doi:10.56238/sevened2023.008-024 · Cited by 2
Bhattacharya, S., Singh, J., Gautam, R. K., Farooqui, N. A., Manocha, N., & Malhotra, H. (2025) · Wiley eBooks · doi:10.1002/9781394237654.ch9 · Cited by 2
Silva, G. L. G. E., de Almeida, B. C., Martins, I. D. C., Dias, C., Santos-Oliveira, R., & Ricci‐Júnior, E. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107047 · Cited by 4
Loch, C. D. O., Souza, P. D. C., Frigieri, I., Isaac, V. L. B., Chiavacci, L. A., Oshiro, J. A., & Chiari‐Andréo, B. G. (2020) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2020.1851247 · Cited by 2
“In the search for these properties of highly structured systems, the characterization tools, such as rheology, microscopy and small angle X-ray scattering, are fundamental for confirming the type of formulation obtained and better understanding of it, being SAXS considered the “gold standard” technique for determinati…”
BackgroundSelf-citationQuality by design-enabled development and characterisation of nanocarrier of azithromycin
Patil, S. R., Gattani, S., Nirbhavane, P., Katare, O. P., & Patil, K. D. (2020) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_43_20 · Cited by 2
Dmitrieva, M. V., Orlova, O. L., Ланцова, А. В., & Krasnyuk, I. I. (2022) · Drug development & registration · doi:10.33380/2305-2066-2022-11-1-82-89 · Cited by 1
Barbosa, T. W. L., Bastos, F. L. A. D. G., da Silva, B. L., Oshiro, J. A., & Chiavacci, L. A. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230328134440 · Cited by 1
Self-citationy Araújo, S. E. D. D. M., Bezerra, B. M. S., Sato, M. R., Macêdo, R. O., & Oshiro, J. A. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113149 · Cited by 1
Fusion of liposomes incorporating α-linolenic acid with the cell plasma membrane is site-restricted
Aljasser, A. A., Said-Elbahr, R., Bosquillon, C., & Stolnik, S. (2025) · Nanoscale · doi:10.1039/d5nr00560d · Cited by 2
Engineering single-layered poly(amidoamine) dendrimer microcapsules for enhanced cellular uptake
Yu, D., Zhang, X., Han, J., Zan, X., Guo, Y. B., & Chen, X. (2025) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2025.2543942 · Cited by 1
“It’s well-documented that physicochemical properties of drug carriers, such as size, shape, chemical composition, charge, and stiffness, significantly affect their cellular interactions [6–11].”
Rangsimawong, W., Duangjit, S., Charoenputtakun, P., Tansathien, K., Ngawhirunpat, T., & Opanasopit, P. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e165253 · Cited by 1
“Although a threshold of ±30 mV is often used to indicate strong electrostatic stabilization of nanoparticles (Manaia et al. 2017), zeta potential values between −10 mV and +10 mV are generally considered indicative of nearly neutral (uncharged) liposomes (Wang et al. 2020).”
A Lecithin Liposome Stimulates Soil Microbial Respiration and Nitrate Immobilization
Butkus, C. R., Weitzman, J. N., Mohammadzadeh, A., Dunn, P. J., Kaye, J. P., Gilbertson, L. M., Little, S. R., & Elliott, E. M. (2025) · ACS Agricultural Science & Technology · doi:10.1021/acsagscitech.5c00587 · Cited by 1
Gobinath, M., Mukherjee, S., Soundarya, R., Halagali, P., Seenivasan, R., Nand, S., Singh, P., & Sharma, H. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100528 · Cited by 3
Potential Ecotoxicological Risk of Nanopharmaceuticals in the Aquatic Environment
Bebianno, M. J., Rocha, T. L., Pontes, J. F., Amaral, A. C., & Grenha, A. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44921-6_8 · Cited by 2
Water-soluble polysiloxane for drug delivery in bioimaging
Lyubova, T. S., Grishin, I. D., Захарычева, Н. С., Александрович, З. Е., Lermontova, S. A., Klapshina, L. G., & Ladilina, E. Y. (2021) · Russian Chemical Bulletin · doi:10.1007/s11172-021-3062-1 · Cited by 1
Nanotechnology for Diagnosis, Imaging, and Treatment of Head and Neck Cancer
Ebrahimi, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-69859-1_4 · Cited by 2
Development of nanoparticles for the Novel anticancer therapeutic agents for Acute Myeloid Leukemia
Bhagwat, A. A., Doke, R. R., Ghule, S. D., & Gandhi, B. R. (2023) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2023.16.4.7 · Cited by 1
Bioactive-Based Nanocarriers for Targeting and Treating Cancer
Priyanka, P., Kumar, S., Sharma, Y., & Karishma (2024) · International Journal of Pharma Professional’s Research (IJPPR) · doi:10.69580/ijppr.15.2.2024.82-95 · Cited by 1
Transformation of Healthcare through Bioimaging and Bioinformatics
Singh, S., & Negi, K. (2024) · International Journal of Pharma Professional’s Research (IJPPR) · doi:10.69580/ijppr.15.2.2024.96-113 · Cited by 2
Abdulla, A. E., Gader, T. K. M., Omer, M. O. W., Gouda, A. E., Mamdouh, S., & Shemis, M. A. (2024) · Advances in Nanoparticles · doi:10.4236/anp.2024.133004 · Cited by 2
Understanding the impact of surfactants on semiconductor CdSe nanoclusters: a computational study
Singh, J., Thareja, R., & Kakkar, R. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06094-0 · Cited by 1
“By integrating DFT studies with experimental validation, it is possible to rationally design synthesis methods that precisely control nanocrystal formation [14].”
Synthesis and self-assembly of polysaccharide-b-elastin-like polypeptide bioconjugates
Xiao, Y. (2019) · theses.fr (ABES) · doi:10.70675/6ef63cffzc57fz4b2azaedcz5d50202fdccb · Cited by 2
Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials
Afonin, K. A. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-260-6 · Cited by 1
Makromolekulás kolloidokból felépülő hatóanyag hordozó rendszerek tervezése
Varga, N. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10658
Modelo tridimensional in vitro de adenocarcinoma prostático humano produzido por levitação magnética
Passos, P. D. Q. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.85.2020.tde-01032021-114311
Silvestrini, A. V. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2021.tde-29092021-104422
Lotierzo, M. C. G. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2021.tde-17122021-104433
Vigato, A. A., Machado, I. P., Franco, M. K. K. D., Yokaichiya, F., de Sairre, M. I., & de Araújo, D. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85754-3.00005-8 · Cited by 1
ศรีขวัญใจ, พ. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.984
Caractérisation des nanoparticules siRNA-Squalène et étude de leur transport et internalisation
Caillaud, M. (2020) · theses.fr (ABES) · doi:10.70675/ee48a49dzc668z4189z8b64zb4773f743619
Gelatin/PLGA Microspheres as a 3D Scaffold for Chondrocytes
Alzubaidi, Z. M., Azmi, F., & Katas, H. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i2.898
Ceylan, S. E., Bulkurcuoğlu, B., Zaichenko, A., Mitina, N., Harhay, K., Finiuk, N. S., & Garamus, V. M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672981-00153
Köse, S., Varan, C., Reçber, T., Nemutlu, E., Bilensoy, E., & Korkusuz, P. (2025) · Methods in molecular biology · doi:10.1007/7651_2025_636
Silva, N. D. D., Attanayake, A. P., & Arawwawala, L. D. A. M. (2025) · ChemistrySelect · doi:10.1002/slct.202500697
Safety considerations in the application of biomaterials for medical purposes
Esther, A., & Greish, K. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26657-7.00017-9
Valdez Aguilar, J. A. (2021) · EspaceINRS (National Institute for Scientific Research (Canada))
Application of thermal therapies and remotely targeted drug delivery systems to treat cancer
Keck, S. (2023) · K-State Research Exchange (Kansas State University)
Roberto, G. T. E. C., Masiero, J. F., Stephano, M. A., & Bou‐Chacra, N. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108267
Ramkumar, P., Muruganantham, V., & Chandira, R. M. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/51589
Electron spectromicroscopy : from organic-inorganic drug nanocarriers to biological systems
Chaupard, M. (2023) · theses.fr (ABES) · doi:10.70675/34ee68f7z6b84z476cz92ccz9dbdfb951ee8
Regulatory Framework and Ethical Considerations In Cancer Nanomedicine
Sirisha, K., Triveni, R., Nirmala, N. V., Chandrika, L. M. D., Kumar, M. P., Maganti, S., & Mekala, K. P. (2025) · doi:10.70593/978-93-7185-359-0_7
Metadata
- Authors
- Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L.
- Affiliations
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Chiavacci, Leila
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-07
- Volume
- Volume 12
- Pages
- 4991-5011
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC5516877
- OpenAlex
- W2734423857
- Cited by
- 207
- References
- 114
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 25 · 2023: 30 · 2022: 29 · 2021: 21 · 2020: 22 · 2019: 17 · 2018: 14
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UNESP Institutional Repository (São Paulo State University) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Estadual Paulista
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- drug nanocarriers, physicochemical characterization, surface charge, porosity, liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, micelles, drug delivery
- MeSH terms
- Dynamic Light Scattering, Drug Carriers, Liposomes, Micelles, Microscopy, Silicon Dioxide, X-Ray Diffraction, Nanotechnology, Microscopy, Electron, Transmission, Nanostructures, Liquid Crystals, Nanoparticles, Scattering, Small Angle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.